Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Huxiang Zhang"'
Autor:
Chang Xu, Danli Peng, Jialu Li, Meihua Chen, Yujie Hu, Mingliang Hou, Qingjuan Shang, Qi Liang, Jie Li, Wenfeng Li, Xiaoli Wu, Changbao Liu, Wanle Hu, Mao Cai, Huxiang Zhang, Guorong Chen, Lingling Yu, Xiaoqun Zheng, Feizhao Jiang, Ju Luan, Shengnan Jin, Chunming Ding
Publikováno v:
BMC Medical Genomics, Vol 13, Iss 1, Pp 1-10 (2020)
Abstract Background Detection of somatic mutations in tumor tissues helps to understand tumor biology and guide treatment selection. Methods such as quantitative PCR can analyze a few mutations with high efficiency, while next generation sequencing (
Externí odkaz:
https://doaj.org/article/0bc5a1db3f2f44f88de0f077b70f45f4
Autor:
Wenrui Sun, Shi Li, Yuan Yu, Honglei Jin, Qipeng Xie, Xiaohui Hua, Shuai Wang, Zhongxian Tian, Huxiang Zhang, Guosong Jiang, Chuanshu Huang, Haishan Huang
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 16, Iss , Pp 519-530 (2019)
Although microRNAs (miRNAs) are well-known for their potential in cancer, the function and mechanisms of miR-3648 have barely been explored in any type of cancer. We show here that miR-3648 is upregulated in human BC tissues in comparison with adjace
Externí odkaz:
https://doaj.org/article/79e2724b74f14fe19c3533d319ae7a42
Autor:
Junjie Chen, Shenmeng Gao, Chunjing Wang, Zhonggai Wang, Huxiang Zhang, Kate Huang, Bin Zhou, Haiying Li, Zhijie Yu, Jianbo Wu, Chengshui Chen
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 35, Iss 1, Pp 1-15 (2016)
Abstract Background The metastatic cascade is a complex and multistep process with many potential barriers. Recently, miR-193a has been reported to be a suppressive miRNA in multiple types of cancers, but its underlying anti-oncogenic activity in non
Externí odkaz:
https://doaj.org/article/1c29705846584c9fa18f5fd0b89e287d
Autor:
Huxiang Zhang, Shenmeng Gao, Jianchao Ying, Haiying Li, Bin Zhou, Jiansheng Wu, Weijian Zhu, Jiajia Li, Hongwei Sun
Publikováno v:
Journal of Cellular and Molecular Medicine
Wilm's tumour‐1 (WT1) is overexpressed in pancreatic ductal adenocarcinoma (PDAC) and enhances metastasis. Deubiquitination stabilizes target proteins, and inhibiting deubiquitination facilitates the degradation of target proteins. However, whether
Autor:
Zhongxian Tian, Wenrui Sun, Guosong Jiang, Yuan Yu, Xiaohui Hua, Huxiang Zhang, Shi Li, Shuai Wang, Chuanshu Huang, Qipeng Xie, Honglei Jin, Haishan Huang
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 16, Iss, Pp 519-530 (2019)
Molecular Therapy. Nucleic Acids
Molecular Therapy. Nucleic Acids
Although microRNAs (miRNAs) are well-known for their potential in cancer, the function and mechanisms of miR-3648 have barely been explored in any type of cancer. We show here that miR-3648 is upregulated in human BC tissues in comparison with adjace
Publikováno v:
International Journal of Rheumatic Diseases
Objective To investigate distinct features of renal involvement in patients with primary Sjögren’s syndrome (pSS) and to identify potential factors associated with renal involvement. Methods Four hundred and thrity‐four pSS patients from the Rhe
Autor:
Ying Guo, Suili Cai, Wen Ma, Ju Luan, Dewen Zhu, Huxiang Zhang, Shiliang Chen, Jinlei Li, Zhengzheng Zhang, Shengnan Jin, Charles R. Cantor, Dandan Li, Xue Liang, Yourong Wang, Feizhao Jiang, Xiaoli Wu, Song Huayu, Tong Lu, Ling Ji, Kuan Li, Zhihai Zheng, Rongxiu Ding, Lingjia Gao, Zhengquan Yang, Chang Xu, Fanggui Shao, Chunming Ding
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Significance Colorectal cancer recurrence is one of the main causes of death. Early prediction of recurrence by minimal residual disease detection and longitudinal tumor monitoring can improve patient outcomes. Next-generation sequencing methods anal
Autor:
Chang-Bao Liu, Xiaoli Wu, Feizhao Jiang, Mao Cai, Lingling Yu, Wenfeng Li, Guorong Chen, Meihua Chen, Chunming Ding, Wan-Le Hu, Huxiang Zhang, Shengnan Jin, Jialu Li, Yujie Hu, Mingliang Hou, Danli Peng, Ju Luan, Xiaoqun Zheng, Chang Xu, Jie Li, Qingjuan Shang, Qi Liang
Publikováno v:
BMC Medical Genomics, Vol 13, Iss 1, Pp 1-10 (2020)
BMC Medical Genomics
BMC Medical Genomics
Background Detection of somatic mutations in tumor tissues helps to understand tumor biology and guide treatment selection. Methods such as quantitative PCR can analyze a few mutations with high efficiency, while next generation sequencing (NGS) base
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eb948c421ba9dbd604f3cc97bfa63c4
https://doi.org/10.21203/rs.2.12726/v4
https://doi.org/10.21203/rs.2.12726/v4
Autor:
Xu, Chang, Danli Peng, Jialu Li, Meihua Chen, Yujie Hu, Mingliang Hou, Qingjuan Shang, Liang, Qi, Li, Jie, Wenfeng Li, Xiaoli Wu, Changbao Liu, Wanle Hu, Cai, Mao, Huxiang Zhang, Guorong Chen, Lingling Yu, Xiaoqun Zheng, Feizhao Jiang, Luan, Ju, Shengnan Jin, Ding, Chunming
Additional file 2 Figure S1. MS assays could detect 5 and 10% mutations mixed by wild-type and mutant plasmids. Figure S2. Genomic alterations of frozen tissues were detected by MALDI-TOF MS and confirmed by Sanger sequencing (A-F). Figure S3. Diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10c492698ac85e44a157b37fe4b58503
Autor:
Jie You1,2, Huxiang Zhang3, Yanyan Shen2, Chuanzhi Chen2, Wenyue Liu4, Minghua Zheng5, Van Poucke, Sven6, Guilong Guo2 wzguoguilong@163.com, Zonghai Huang1 dr_huangzh@126.com
Publikováno v:
OncoTargets & Therapy. Apr2017, Vol. 10, p2199-2207. 9p.